QPS Appoints Dr. Luca C. Matassa as New Vice President and Head of Bioanalysis - June, 2013

Newark, DE; June 28, 2013 - QPS is pleased to announce that Dr. Luca C. Matassa has joined as Vice President and Head of Bioanalysis in Delaware. Dr Matassa, will head QPS, LLC’s Delaware regulated unit for bioanalysis which includes method development, validation and samples analysis using chromatographic methods as well as related support services including sample management, laboratory equipment & coordination, technical report writing, and archiving.

Dr. Matassa brings deep scientific and leadership experience to QPS, with over twenty-five years in bioanalysis, most recently as a consultant for the Eisai pharmaceutical company. Before that, he served in management and leadership roles with Tandem Labs, Covance and Maxxam Analytics.

“Luca’s accomplishments in establishing, expanding, and improving bioanalysis services at Covance and Tandem are especially impressive,” said QPS Chief Executive Officer Dr. Ben Chien. “We are certain that, given his depth of process knowledge and industry experience, Dr. Matassa will provide a high level of service for our clients.”

Dr. Matassa received his Ph.D. in Organic Chemistry from The University of Windsor, Ontario, Canada and his B.S. in Honors Chemistry from the same university. He will be based at QPS Headquarters in Newark, Delaware, and report to Dr. Kumar Ramu, COO.

About QPS

QPS is a GLP/GCP-compliant CRO that supports discovery and preclinical and clinical drug development. We provide quality services in Neuropharmacology, Drug Metabolism and Pharmacokinetics, Toxicology, Bioanalysis, Translational Medicine, and Early & Late Phase Clinical Research to clients worldwide. Our 30+ regional laboratories, clinical facilities and offices are located in North America, Europe and Asia. For more information, visit


Reinier Schwietert 
Vice President of Global Marketing
QPS Holdings, LLC
Delaware Technology Park
3 Innovation Way, Suite 240
Newark, DE 19711
+31 (50) 304 8003

20 years in pharma R&D navigation